12/07/2026
The treatment landscape for hidradenitis suppurativa is rapidly evolving.
This review by Pender et al. covers both licensed and off-license options currently available, and looks ahead at the biologics and small molecules making their way through Phase 2 and 3 clinical trials. 🔬
The full review is just one click away 👉 https://bit.ly/4bYlmI0